GeNeuro SA (FRA:GEM)
Germany flag Germany · Delayed Price · Currency is EUR
0.0362
+0.0012 (3.43%)
At close: Nov 28, 2025

GeNeuro Statistics

Total Valuation

GeNeuro has a market cap or net worth of EUR 1.26 million.

Market Cap1.26M
Enterprise Value n/a

Important Dates

The next estimated earnings date is Friday, February 6, 2026.

Earnings Date Feb 6, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 29.60M
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) -0.07%
Owned by Insiders (%) n/a
Owned by Institutions (%) 0.32%
Float 10.05M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio -0.09
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.37

Current Ratio 0.37
Quick Ratio 0.29
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -1.35
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -100.64%
Return on Invested Capital (ROIC) -211.83%
Return on Capital Employed (ROCE) -12,773.40%
Revenue Per Employee n/a
Profits Per Employee -868,059
Employee Count 17
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, GeNeuro has paid 4,200 in taxes.

Income Tax 4,200
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -61.89% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -61.89%
50-Day Moving Average 0.04
200-Day Moving Average 0.05
Relative Strength Index (RSI) 54.43
Average Volume (20 Days) 1,843

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -14.36M
Pretax Income -14.75M
Net Income -14.76M
EBITDA -14.32M
EBIT -14.36M
Earnings Per Share (EPS) -0.59
Full Income Statement

Balance Sheet

The company has 1.83 million in cash and 13.67 million in debt, giving a net cash position of -11.84 million.

Cash & Cash Equivalents 1.83M
Total Debt 13.67M
Net Cash -11.84M
Net Cash Per Share n/a
Equity (Book Value) -13.78M
Book Value Per Share -0.55
Working Capital -3.92M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.15 million and capital expenditures -12,500, giving a free cash flow of -10.16 million.

Operating Cash Flow -10.15M
Capital Expenditures -12,500
Free Cash Flow -10.16M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GeNeuro does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.96%
Shareholder Yield -3.96%
Earnings Yield -1,170.45%
FCF Yield -805.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1